{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:22:35Z","timestamp":1783556555049,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.talanta.2019.120593","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T02:13:08Z","timestamp":1574734388000},"page":"120593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Implementation of lipidomics in clinical routine: Can fluoride\/citrate blood sampling tubes improve preanalytical stability?"],"prefix":"10.1016","volume":"209","author":[{"given":"Lisa","family":"Hahnefeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gurke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan M.G.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Trautmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Faria","family":"Snodgrass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Geisslinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Ferreir\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.talanta.2019.120593_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/14737159.2018.1481391","article-title":"A review of validated biomarkers obtained through metabolomics","volume":"18","author":"L\u00f3pez-L\u00f3pez","year":"2018","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"5","key":"10.1016\/j.talanta.2019.120593_bib2","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1111\/cas.14005","article-title":"New era of research on cancer-associated glycosphingolipids","volume":"110","author":"Furukawa","year":"2019","journal-title":"Cancer Sci."},{"issue":"7","key":"10.1016\/j.talanta.2019.120593_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1753944718773690","article-title":"Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease","volume":"12","author":"Martin Gimenez","year":"2018","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.talanta.2019.120593_bib4","series-title":"Guideline on Bioanalytical Method Validation, 2009 Rev. 1 Corr","first-page":"2","year":"2009"},{"key":"10.1016\/j.talanta.2019.120593_bib5","series-title":"Center for Drug Evaluation and Research","author":"US FDA UDoHaHS","year":"2018"},{"issue":"18","key":"10.1016\/j.talanta.2019.120593_bib6","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/elps.201700086","article-title":"A review of blood sample handling and pre-processing for metabolomics studies","volume":"38","author":"Hernandes","year":"2017","journal-title":"Electrophoresis"},{"issue":"4","key":"10.1016\/j.talanta.2019.120593_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11040520","article-title":"Challenges and inconsistencies in using lysophosphatidic acid as a biomarker for ovarian cancer","volume":"11","author":"Yagi","year":"2019","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.talanta.2019.120593_bib8","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1373\/clinchem.2012.199257","article-title":"Preanalytical aspects and sample quality assessment in metabolomics studies of human blood","volume":"59","author":"Yin","year":"2013","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.talanta.2019.120593_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1373\/clinchem.2013.211979","article-title":"Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling","volume":"60","author":"Kamlage","year":"2014","journal-title":"Clin. Chem."},{"issue":"17","key":"10.1016\/j.talanta.2019.120593_bib10","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1007\/s00216-015-8565-x","article-title":"Effects of pre-analytical processes on blood samples used in metabolomics studies","volume":"407","author":"Yin","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"issue":"1","key":"10.1016\/j.talanta.2019.120593_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/metabo8010006","article-title":"Impact of prolonged blood incubation and extended serum storage at room temperature on the human serum Metabolome","volume":"8","author":"Kamlage","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.talanta.2019.120593_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.aca.2015.08.049","article-title":"Phenylmethanesulfonyl fluoride pretreatment stabilizes plasma lipidome in lipidomic and metabolomic analysis","volume":"893","author":"Wang","year":"2015","journal-title":"Anal. Chim. Acta"},{"issue":"5","key":"10.1016\/j.talanta.2019.120593_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051390","article-title":"Preanalytical biases in the measurement of human blood sphingolipids","volume":"19","author":"Brunkhorst","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.talanta.2019.120593_bib14","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1194\/jlr.D050070","article-title":"Challenges in accurate quantitation of lysophosphatidic acids in human biofluids","volume":"55","author":"Onorato","year":"2014","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.talanta.2019.120593_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ab.2007.05.004","article-title":"Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids","volume":"367","author":"Nakamura","year":"2007","journal-title":"Anal. Biochem."},{"issue":"10","key":"10.1016\/j.talanta.2019.120593_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2183\/pjab.94.025","article-title":"Lysophospholipids in laboratory medicine","volume":"94","author":"Yatomi","year":"2018","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"5","key":"10.1016\/j.talanta.2019.120593_bib17","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1194\/jlr.D043794","article-title":"Analysis of ECs and related compounds in plasma: artifactual isomerization and ex vivo enzymatic generation of 2-MGs","volume":"55","author":"Pastor","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.talanta.2019.120593_bib18","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.talanta.2018.04.033","article-title":"Study of sample preparation for determination of endocannabinoids and analogous compounds in human serum by LC\u2013MS\/MS in MRM mode","volume":"185","author":"Luque-C\u00f3rdoba","year":"2018","journal-title":"Talanta"},{"issue":"3","key":"10.1016\/j.talanta.2019.120593_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1194\/jlr.M021378","article-title":"Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC\/MS\/MS","volume":"53","author":"Fanelli","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.talanta.2019.120593_bib20","series-title":"Determination of Endocannabinoids and Endocannabinoid-like Substances in Human K3EDTA Plasma \u2013 LC-MS\/MS Method Validation and Pre-analytical Characteristics","author":"Gurke","year":"2019"},{"key":"10.1016\/j.talanta.2019.120593_bib21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.aca.2013.01.015","article-title":"UPLC-ESI-QTOF\/MS and multivariate data analysis for blood plasma and serum metabolomics: effect of experimental artefacts and anticoagulant","volume":"768","author":"Barri","year":"2013","journal-title":"Anal. Chim. Acta"},{"issue":"5","key":"10.1016\/j.talanta.2019.120593_bib22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1373\/clinchem.2008.121707","article-title":"Acidification of blood is superior to sodium fluoride alone as an inhibitor of glycolysis","volume":"55","author":"Gambino","year":"2009","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.talanta.2019.120593_bib23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/bi051558s","article-title":"Fluoride inhibition of enolase: crystal structure and thermodynamics","volume":"45","author":"Qin","year":"2006","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.talanta.2019.120593_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16081427","article-title":"Fluoride exposure induces inhibition of sodium-and potassium-activated adenosine triphosphatase (Na(+), K(+)-ATPase) enzyme activity: molecular mechanisms and implications for public health","volume":"16","author":"Waugh","year":"2019","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.talanta.2019.120593_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/0960327118814161","article-title":"Exploring the role of excess fluoride in chronic kidney disease: a review","volume":"38","author":"Dharmaratne","year":"2019","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.talanta.2019.120593_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.metabol.2019.04.002","article-title":"Targeted lipidomics reveal derangement of ceramides in major depression and bipolar disorder","volume":"95","author":"Brunkhorst-Kanaan","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.talanta.2019.120593_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biocel.2019.05.002","article-title":"GPER1 influences cellular homeostasis and cytostatic drug resistance via influencing long chain ceramide synthesis in breast cancer cells","volume":"112","author":"Wegner","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.talanta.2019.120593_bib28","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","article-title":"Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics","volume":"49","author":"Matyash","year":"2008","journal-title":"J. Lipid Res."},{"issue":"1\u20132","key":"10.1016\/j.talanta.2019.120593_bib29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.talanta.2019.120593_bib30","series-title":"A Language and Environment for Statistical Computing","author":"R Development Core Team","year":"2008"},{"key":"10.1016\/j.talanta.2019.120593_bib31","series-title":"RStudio: Integrated Development for R.","year":"2016"},{"key":"10.1016\/j.talanta.2019.120593_bib32","unstructured":"F.H. Bretz, Torsten; Westfall, Peter, Multiple Comparisons Using R, Boca Raton: CRC Press2010."},{"key":"10.1016\/j.talanta.2019.120593_bib33","series-title":"R Core Team, Nlme: Linear and Nonlinear Mixed Effects Models, R Package Version 3.1-140","author":"Pinheiro J","year":"2019"},{"key":"10.1016\/j.talanta.2019.120593_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jchromb.2011.06.025","article-title":"Simultaneous UPLC-MS\/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG\/1AG isomerization and degradation by toluene solvent extraction","volume":"883\u2013884","author":"Zoerner","year":"2012","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2019.120593_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00166","article-title":"Metabolism of the endocannabinoid anandamide: open questions after 25 years","volume":"10","author":"Maccarone","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.talanta.2019.120593_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0009-3084(02)00068-3","article-title":"Chemical stability of 2-arachidonylglycerol under biological conditions","volume":"119","author":"Rouzer","year":"2002","journal-title":"Chem. Phys. Lipids"},{"issue":"3","key":"10.1016\/j.talanta.2019.120593_bib37","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ymeth.2004.03.021","article-title":"Ions from the Hofmeister series and osmolytes: effects on proteins in solution and in the crystallization process","volume":"34","author":"Collins","year":"2004","journal-title":"Methods"},{"issue":"7","key":"10.1016\/j.talanta.2019.120593_bib38","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.1039\/C6CP08214A","article-title":"Effects of the Hofmeister series of sodium salts on the solvent properties of water","volume":"19","author":"Ferreira","year":"2017","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"8","key":"10.1016\/j.talanta.2019.120593_bib39","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1194\/jlr.D094680","article-title":"Quantification of 24 circulating endocannabinoids, endocannabinoid-related compounds and their phospholipid precursors in human plasma by UHPLC-MS\/MS","volume":"60","author":"Roehrig","year":"2019","journal-title":"JLR (J. Lipid Res.)"},{"issue":"5","key":"10.1016\/j.talanta.2019.120593_bib40","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/1055-9965.EPI-15-1206","article-title":"Impact of pre-analytic blood sample collection factors on metabolomics","volume":"25","author":"Townsend","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914019312263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914019312263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T12:29:23Z","timestamp":1758544163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914019312263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":40,"alternative-id":["S0039914019312263"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2019.120593","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementation of lipidomics in clinical routine: Can fluoride\/citrate blood sampling tubes improve preanalytical stability?","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2019.120593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120593"}}